Sebia Acquires Orgentec Diagnostika
The strategic acquisition reinforces Sebia’s global leadership in specialty diagnostics LISSES, France, June 30, 2021 /PRNewswire/ — Sebia, a leading provider of clinical protein electrophoresis equipment and reagents for diabetes and oncology detection, today announced the acquisition…